SAFARIKIA, Samira
 Distribuzione geografica
Continente #
NA - Nord America 567
EU - Europa 340
AS - Asia 112
AF - Africa 6
SA - Sud America 3
OC - Oceania 2
Totale 1.030
Nazione #
US - Stati Uniti d'America 556
IT - Italia 139
IE - Irlanda 64
SG - Singapore 54
SE - Svezia 48
FI - Finlandia 27
IN - India 23
CN - Cina 20
DE - Germania 18
NL - Olanda 11
RU - Federazione Russa 8
CA - Canada 7
ID - Indonesia 7
BG - Bulgaria 6
GB - Regno Unito 5
TG - Togo 5
CR - Costa Rica 4
JP - Giappone 4
RO - Romania 4
AR - Argentina 2
FR - Francia 2
HK - Hong Kong 2
HU - Ungheria 2
TR - Turchia 2
UA - Ucraina 2
AU - Australia 1
BE - Belgio 1
BO - Bolivia 1
EE - Estonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
RS - Serbia 1
ZA - Sudafrica 1
Totale 1.030
Città #
Fairfield 92
Dublin 63
Chandler 52
Woodbridge 45
Rome 44
Ashburn 41
Cambridge 33
Singapore 29
Seattle 28
Houston 27
Helsinki 26
Wilmington 26
Santa Clara 22
Fremont 18
Princeton 13
San Paolo di Civitate 12
Millbury 10
Ann Arbor 9
Lawrence 9
Dearborn 7
Jakarta 7
Plano 6
Sofia 6
Falkenstein 5
Lomé 5
Redwood City 5
Toronto 5
Catania 4
Milan 4
Nishinotoindori 4
Phoenix 4
San José 4
Venezia 4
Amsterdam 3
Beijing 3
Boston 3
Bremen 3
San Diego 3
Andover 2
Boardman 2
Bologna 2
Budapest 2
Federal 2
Fiuggi 2
Formigine 2
Hong Kong 2
Livorno 2
Los Angeles 2
Montreal 2
New York 2
Norwalk 2
Romainville 2
San Severo 2
Shanghai 2
Ariccia 1
Baotou 1
Birr 1
Brussels 1
Bühl 1
Castelnuovo Di Porto 1
Columbus 1
Dallas 1
Des Moines 1
Dunedin 1
Falls Church 1
Grafing 1
Guangzhou 1
Guidonia 1
Hangzhou 1
Huzhou 1
Hyderabad 1
Istanbul 1
Jinan 1
Killeen 1
Kunming 1
La Paz 1
Latina 1
Leawood 1
London 1
Meda 1
Monza 1
Moscow 1
Munich 1
Nanning 1
Oslo 1
Pisa 1
Pune 1
Sacramento 1
Silverton 1
Slough 1
Southwark 1
Sydney 1
Tallinn 1
Torre Santa Susanna 1
Trabzon 1
Totale 757
Nome #
DCLK1, a putative novel stem cell marker in human cholangiocarcinoma 131
The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma 124
Simulated microgravity promotes the formation of tridimensional cultures and stimulates pluripotency and a glycolytic metabolism in human hepatic and biliary tree stem/progenitor cells 120
Functions and the emerging role of the foetal liver into regenerative medicine 112
Contribution of resident stem cells to liver and biliary tree regeneration in human diseases 90
New insights into cholangiocarcinoma: multiple stems and related cell lineages of origin 80
HUMAN DUODENAL SUBMUCOSAL GLANDS CONTAIN STEM CELLS WITH POTENTIAL FOR LIVER AND PANCREATIC FATES 68
Increased liver localization of lipopolysaccharides in human and experimental NAFLD 66
Microgravity maintains stemness and enhance glycolytic metabolism in human hepatic and biliary tree stem/progenitor cells 58
Hyaluronan-based grafting strategies for liver stem cell therapy and tracking methods 56
Distinct EpCAM-Positive stem cell niches are engaged in chronic and neoplastic liver diseases 53
null 52
Different micro-environtmental factors induce proliferation, epithelial-mesenchymal transition (EMT) and senescence of primary cultures of human biliary tree stem/progenitor cells (hBTSCs), recapitulating the pathological features typical of human cholangiopathies 39
Development of self-renewing 3D organoid culture from human fetal biliary tree stem cells (hBTSCs) as a potential system for regenerative medicine and disease modelling 12
The cancerogenic potential of primary human Cholangioracinoma cells is inhibited by Obeticholic Acid, a Farnesoid X Receptor (FXR) agonist 12
The FXR Agonist, Obeticholic Acid, Inhibits the Cancerogenic Potential of Primary Human Cholangiocarcinoma Cells: a Study on Primary Human Cell Cultures 10
Obeticholic acid, a FXR agonist, inhibits the cancerogenic potential of primary human cholangiocarcinoma (CCA) cells cultures 8
THU-457-DoubleCortin/Like Kinase 1 (DCLK1) expression characterized specific cancer stem cell subpopulations of human cholangiocarcinoma primary cell cultures where its inhibition exerts anti-neoplastic effects 8
null 5
Specific human cholangiocarcinoma (CCA) subpopulations of cancer stem cells (CSCs) express DoubleCortin-Like Kinase 1 (DCLK1) and DCLK1 inhibition induces anti-cancer effects 5
The exposure of primary cultures of human biliary tree stem/progenitor cells (hBTSCs) to different micro-environmental factors induces proliferation, epithelial-mesenchymal transition (EMT) and senescence, which are typical pathological features of human cholangiopathies 4
OC.08.1 DOUBLECORTIN-LIKE KINASE 1 (DCLK1) IS A MARKER OF SPECIFIC SUBPOPULATIONS OF CANCER STEM CELLS (CSCS) IN HUMAN CHOLANGIOCARCINOMA (CCA) AND ITS INHIBITION EXERTS ANTI-CANCER EFFECTS 4
null 4
null 4
null 4
null 4
null 3
null 3
A new strategy to improve the liver engraftment efficiency of transplanted human biliary tree stem/progenitor cells: cell coating with hyaluronic acid 3
null 3
OC.01.1 BILIARY TREE STEM CELLS PLAY A KEY ROLE IN THE REGENERATION OF BILIARY EPITHELIUM AFTER INJURY 2
Establishment of expanding 3D-organoids cultures from human fetal biliary tree stem cells (hBTSCs) as a potential tool for regenerative medicine and disease modeling 2
OC.04.1 GENERATION OF 3D ORGANOIDS OF HUMAN FETAL BILIARY TREE STEM CELLS (HBTSCS) AS INNOVATIVE TOOL FOR THE REGENERATIVE MEDICINE OF LIVER AND PANCREAS 1
P.10.2: Hyaluronic Acid Improves the Engraftment Efficiency of Human Biliary Tree Stem/Progenitor Cells (HBTSCS) 1
Simulated microgravity significantly impacts the differentiation and metabolism of human hepatic and biliary tree stem/progenitor cells 1
P.04.6 PRIMARY HUMAN BILIARY TREE STEM/PROGENITOR CELLS (HBTSCS) EXPOSED TO MICROENVIRONMENTAL FACTORS SHOWED PROLIFERATION, EPITHELIAL-MESENCHYMAL TRANSITION (EMT) AND SENESCENCE, RECAPITULATING THE PATHOLOGICAL FEATURES TYPICAL OF HUMAN CHOLANGIOPATHIES 1
Different micro-environtmental factors induce proliferation, epithelial-mesenchymal transition (EMT) and senescence of primary cultures of human biliary tree stem/progenitor cells (hBTSCs), recapitulating the pathological features typical of human cholangiopathies 1
Totale 1.154
Categoria #
all - tutte 3.728
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.728


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020120 0 0 0 0 0 28 28 18 18 11 9 8
2020/2021166 3 10 1 13 25 23 5 5 21 37 19 4
2021/2022192 13 5 20 13 21 8 4 15 11 10 47 25
2022/2023259 33 55 22 13 14 20 2 16 71 2 6 5
2023/202498 5 13 2 3 25 15 5 13 0 8 4 5
2024/2025195 10 10 16 24 96 39 0 0 0 0 0 0
Totale 1.154